Paytm, MobiKwik, Pine Labs shares tumble up to 7% on reports of further UPI MDR delay. What's next?
Shares of Paytm, MobiKwik and Pine Labs fell after reports suggested that the rollout of merchant discount rates (MDR) on select UPI transactions could face further delays, potentially extending beyond the 2027 assembly elections in five states. T...

Paytm, MobiKwik and Pine Labs fell on reports that MDR charges on select UPI transactions could be delayed.
Shares of One 97 Communications, the operator of UPI giant Paytm, tumbled 7% to trade at Rs 1,765 apiece on NSE. One Mobikwik Systems shares also dropped 7% to Rs 211.53 apiece, while Pine Labs shares fell nearly 6% to Rs 160 apiece on Thursday morning.
The possible delay of the UPI MDR fee till beyond the 2027 polls comes as the government remains cautious of a potential backlash from merchants and trade associations, The Financial Express reported citing industry sources. This comes as Uttar Pradesh, Punjab, Uttarakhand, Goa and Manipur are set to go to polls in the first half of next year.
This comes after the National Payments Corporation of India (NPCI) last month delayed the implementation of the MDR fee beyond Diwali, which led to a sharp drop in the shares of the fintech firms as they missed the key festive season. Earlier, the new fee structure was scheduled to take effect from October 15 onwards.
Also read | UPI MDR rollout deferred until after Diwali
The NPCI in September had announced that a Merchant Discount Rate (MDR) on select Person-to-Merchant (P2M) UPI transactions above Rs 2,000. However, it received strong criticism from retail traders’ associations, leading to delays.
Sources told The Economic Times that the Payments Council of India (PCI) has made multiple representations to the finance ministry and NPCI, seeking an early announcement of the final implementation date for merchant discount rate (MDR) on select UPI transactions.
Also read | Payment firms seek early MDR rollout for select UPI transactions while they stay 18 months without incentives
Why are Paytm, Pine Labs shares crashing?
Paytm and Pine Labs were seen as the biggest beneficiaries in the MDR regime, positioned to capture the larger absolute opportunity. Paytm had said the introduction of the fee will generate additional revenue from the merchant business for many of the payment transactions that were free earlier. Brokerages hiked their target prices and earnings estimates for the fintech platform following the announcement.Paytm is positioned to capture the larger absolute opportunity, with analysts estimating FY28 UPI MDR revenue of as much as Rs 1,160 crore, before the delays were announced. Pine Labs, with a smaller UPI base, could see a sharper impact on earnings, with the new revenue stream potentially contributing about 20% to its EBIT and profit before tax estimates.
Jefferies estimated that Pine Labs could generate Rs 1.6 billion of incremental revenue from UPI MDR in FY28. That would represent about 20% of its EBIT and profit before tax estimates, while the report’s sensitivity analysis indicates an impact of about 14% on adjusted EBITDA. This is why the reports on MDR rollout delays spooked investors, leading to a sharp drop in these stocks.
Also read | UPI MDR bonanza: Why Paytm may win bigger, but Pine Labs could gain faster
Disclaimer: This article has been written by Debaroti Adhikary, who is not a SEBI-registered Research Analyst or an Investment Adviser. Debaroti Adhikary and his/her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here.
Download ET Markets APP